Skip to main content

Articles

Page 1 of 12

  1. Renal cell carcinoma (RCC) is the most common type of kidney cancer. VEGF inhibitors and mTORs are the most common therapeutic options among the different classes of available treatments. In this study, the ef...

    Authors: Zahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, Mojtaba Jafari, Iman Mirian, Amir Hashemi Meshkini, Khosro Keshavarz and Younes Ghasemi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:10
  2. Congenital cytomegalovirus (cCMV) infection can cause severe neurological damage, growth retardation, hearing loss, and microcephaly in infants. We aimed at assessing healthcare costs of infants with recorded ...

    Authors: Anna-Janina Stephan, Marion de Lepper, Regine Wölle, Agnes Luzak, Wei Wang, Christian Jacob, Kim Maren Schneider, Horst Buxmann, Rangmar Goelz, Klaus Hamprecht, Peter Kummer, Susanne Modrow, Wolfgang Greiner and Miriam Reuschenbach
    Citation: Cost Effectiveness and Resource Allocation 2023 21:8
  3. This article aims to summarize the development and challenges of real-world data (RWD) and real-world evidence (RWE) in China and introduce a unique opportunity for medical devices to gain accelerated regulato...

    Authors: Jiahe Li, Lichang Liu, Haijun Cao, Mei Yang and Xin Sun
    Citation: Cost Effectiveness and Resource Allocation 2023 21:7
  4. Atezolizumab has recently been approved for first-line treatment of high PD-L1 expression metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with no EGFR or ALK mutations, on the basis of the IMpower110 tr...

    Authors: Dolores Isla, Marta Lopez-Brea, María Espinosa, Natalia Arrabal, Diego Pérez-Parente, David Carcedo and Reyes Bernabé-Caro
    Citation: Cost Effectiveness and Resource Allocation 2023 21:6
  5. Bladder cancer is one of the most prevalent and costly cancers in the world. Estimating the economic burden of bladder cancer is essential for allocating resources to different sectors of health systems and de...

    Authors: Mehdi Raadabadi, Rajabali Daroudi, Kazem Zendehdel, Ali Akbar Haghdoost, Mohammad Reza Ebadzadeh and Hamideh Rashidian
    Citation: Cost Effectiveness and Resource Allocation 2023 21:5
  6. Stereotactic ablative radiotherapy (SABR) is recommended as first-choice treatment to inoperable early-stage non-small cell lung cancer (NSCLC). However, it is not widely adopted in developing countries, and i...

    Authors: Fernando Henrique de Albuquerque Maia, Luciana Martins Rozman, Heloisa de Andrade Carvalho and Patrícia Coelho de Soárez
    Citation: Cost Effectiveness and Resource Allocation 2023 21:4
  7. Total hip arthroplasty (THA) is the most common treatment for primary and secondary end-stage hip osteoarthritis (OA). Almost 20% of all patients undergoing primary THA suffer from bilateral hip OA and, conseq...

    Authors: Pierluigi Pironti, Andrea Ambrosanio, Valeria Vismara, Marco Viganò, Eugenia Bucci, Paolo Sirtori, Giuseppe M Peretti and Laura Mangiavini
    Citation: Cost Effectiveness and Resource Allocation 2023 21:3

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:9

  8. It can be challenging to diagnose the cause of a patient’s dizziness. Patients face significant delays before receiving a correct diagnosis as they will undergo many diagnostic tests under several different me...

    Authors: John S Phillips and Jacob Newman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:2
  9. Image-guided system (IGS) has been gradually applied in the field of rhinology, making functional endoscopic sinus surgery (FESS) a truly minimally invasive and precise surgery. This study was based on real-wo...

    Authors: Zaixing Wang, Chunling Liu, Baoying Tan, Guoqing Sun, Poucheok Pang, Kangchen lv, Hui Xie, Xiong Ou, Xianhai Zeng and Jianwei Xuan
    Citation: Cost Effectiveness and Resource Allocation 2023 21:1
  10. Unequal utilization of medical services will have a significant impact on the consumption of resources entitled through health insurance claims of patients. With the proposal of the goal of Healthy China, it i...

    Authors: Lele Li, Xiaotong He, Yixuan Li, Xiangyu Chen, Xue Wang and Chunhou Li
    Citation: Cost Effectiveness and Resource Allocation 2022 20:74
  11. Has the medical arms race (MAR) increased healthcare expenditures? Existing literature has yet to draw a consistent conclusion. Hence, this study aims to reexamine the relationship between the MAR and medical ...

    Authors: Paicheng Liu, Xue Gong, Qianhui Yao and Qiong Liu
    Citation: Cost Effectiveness and Resource Allocation 2022 20:73
  12. Surgical lung resection involves a critical task of stapled ligation and transection of major vascular structures and tissue, which may lead to bleeding and complications. A newer powered stapling system with ...

    Authors: Chongzhi Gan, Fuchun Zeng, Wei Cong, Tiange Tang and Gang Feng
    Citation: Cost Effectiveness and Resource Allocation 2022 20:72
  13. Governments in Latin America are constantly facing the problem of managing scarce resources to satisfy alternative needs, such as housing, education, food, and healthcare security. Those needs, combined with i...

    Authors: Arcadio A. Cerda, Leidy Y. García, Jennifer Rivera-Arroyo, Andrés Riquelme, Joao Paulo Teixeira and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2022 20:71
  14. Preparation and financing of treatments, control of disease by limited resources, are known as the most important challenges encountered by the policy-makers involved in an epidemic outbreak. Therefore, the pr...

    Authors: Zeynab Farhadi, Morteza Salemi and Mohammad Ali Jahani
    Citation: Cost Effectiveness and Resource Allocation 2022 20:70
  15. Multiple myeloma is an incurable haematological malignancy that is associated with a high probability of relapse. The survival of relapsed patients has been greatly improved by the development of novel drugs s...

    Authors: Lineo Marie Matsela, Susan Cleary and Thomas Wilkinson
    Citation: Cost Effectiveness and Resource Allocation 2022 20:69
  16. The rising incidence of breast cancer places a financial burden on national health services and economies. The objective of this review is to present a detailed analysis of the research and literature on indir...

    Authors: Saeed Mohammadpour, Samira Soleimanpour, Javad Javan-Noughabi, Nasrin Aboulhasanbeigi Gallehzan, Ali Aboutorabi, Reza Jahangiri, Rafat Bagherzadeh, Julia F. Gorman and Ali Nemati
    Citation: Cost Effectiveness and Resource Allocation 2022 20:68
  17. In the past decades, highly innovative treatments in the field of diffuse large B-cell lymphoma (DLBCL) became available in clinical practice. The aim of this study was to assess the cost–benefit relation of t...

    Authors: Florian Jakobs, Julia Jeck, Paymon Ahmadi, Anna Kron and Florian Kron
    Citation: Cost Effectiveness and Resource Allocation 2022 20:67
  18. The present study aimed to examine the cost-effectiveness of fractional flow reserve (FFR) versus angiography in treating borderline coronary lesions in patients with coronary artery stenosis in Iran. Cardiova...

    Authors: Khosro Keshavarz, Rita Rezaee, Elahe Esmaili, Roohollah Mansouri, Abdosaleh Jafari, Azadeh Erami, Hamid Talebianpour, Ricardo Fonseca and Mozhgan Fardid
    Citation: Cost Effectiveness and Resource Allocation 2022 20:66
  19. An inefficient health system wastes scarce resources even if it makes considerable gains in accountability and equity. Such a system is expected to perform better. Therefore, it is vital to examine the current...

    Authors: Siamak Aghlmand, Sadegh Feizollahzadeh, Behrouz Fathi, Hasan Yusefzadeh and Mina Alinejhad
    Citation: Cost Effectiveness and Resource Allocation 2022 20:65
  20. Autoimmune thyroid diseases are the most common diseases in humans. Their pathogenesis is complex, pushing patients to search different ways of alleviating their effects, one of which is diet change. The aim o...

    Authors: Ewa Czubek, Klaudia Alcer, Mirjana Varjacic and Piotr Romaniuk
    Citation: Cost Effectiveness and Resource Allocation 2022 20:63
  21. This study was aimed to systematically review published economic studies to determine whether dapagliflozin, a sodium-glucose co-transporter inhibitor, plus standard care therapy (SCT) is cost-effective in hea...

    Authors: Ghader Mohammadnezhad, Behniya Azadmehr, Mehdi Mirheidari and Nazila Yousefi
    Citation: Cost Effectiveness and Resource Allocation 2022 20:62
  22. To assess the cost-effectiveness of the delayed-release device of dexamethasone compared with aflibercept in the treatment of patients with naïve diabetic macular edema (DME) from a societal perspective in the...

    Authors: Paula Montes Rodríguez, Javier Mateo Gabás, Olivia Esteban Floría, Ana Honrubia Grijalbo and Francisco J. Ascaso Puyuelo
    Citation: Cost Effectiveness and Resource Allocation 2022 20:61
  23. Numerous studies have shown the effectiveness of testing for hepatitis B (HBV) and hepatitis C (HCV) in emergency departments (ED), due to the elevated prevalence amongst attendees. The aim of this study was t...

    Authors: Jack Williams, Peter Vickerman, Elizabeth Smout, Emma E. Page, Khine Phyu, Mark Aldersley, Gaia Nebbia, Sam Douthwaite, Laura Hunter, Murad Ruf and Alec Miners
    Citation: Cost Effectiveness and Resource Allocation 2022 20:60
  24. There is level 1 evidence for cerebral thrombectomy with thrombolysis in acute large vessel occlusion. Many hospitals are now contemplating setting up this life-saving service. For the hospital, however, the f...

    Authors: Iris Q. Grunwald, Viola Wagner, Anna Podlasek, Gouri Koduri, Paul Guyler, Stephen Gerry, Sweni Shah, Horst Sievert, Aarti Sharma, Shrey Mathur, Klaus Fassbender, Kaveh Shariat, Graeme Houston, Avinash Kanodia and Silke Walter
    Citation: Cost Effectiveness and Resource Allocation 2022 20:59
  25. Associations between the COVID-19 pandemic and hospitalizations have not been studied Iran. This study aimed to examine the impact of the COVID-19 pandemic on hospital admissions for nine categories of disease...

    Authors: Sina Ahmadi, Ali Kazemi-Karyani, Nasim Badiee, Sarah Byford, Ali Mohammadi, Bakhtiar Piroozi and Satar Rezaei
    Citation: Cost Effectiveness and Resource Allocation 2022 20:58
  26. The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy...

    Authors: Charles C. Ezenduka, Abudulahi Namadi, Dahiru Tahir, Uzoma Nwosu and Shuaibu N. Musa
    Citation: Cost Effectiveness and Resource Allocation 2022 20:57
  27. Empirical estimates of health system opportunity costs have been suggested as a basis for the cost-effectiveness threshold to use in Health Technology Assessment. Econometric methods have been used to estimate...

    Authors: Karla Hernandez-Villafuerte, Bernarda Zamora, Yan Feng, David Parkin, Nancy Devlin and Adrian Towse
    Citation: Cost Effectiveness and Resource Allocation 2022 20:56
  28. This study was an ex-ante cost-utility analysis of deemed consent legislation for deceased organ donation in Nova Scotia, a province in Canada. The legislation became effective in January 2021. The study's obj...

    Authors: Prosper Koto, Karthik Tennankore, Amanda Vinson, Kristina Krmpotic, Matthew J. Weiss, Chris Theriault and Stephen Beed
    Citation: Cost Effectiveness and Resource Allocation 2022 20:55
  29. Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical de...

    Authors: Jian Ming, Yunzhen He, Yi Yang, Min Hu, Xinran Zhao, Jun Liu, Yang Xie, Yan Wei and Yingyao Chen
    Citation: Cost Effectiveness and Resource Allocation 2022 20:54
  30. The prevalence of heart failure (HF) is increasing in the ageing world population, and its burden on the medical and health economic fields is enormous. Rehabilitation is an essential component of the nonpharm...

    Authors: Kotomi Sakai, Ryo Momosaki and Eri Hoshino
    Citation: Cost Effectiveness and Resource Allocation 2022 20:53
  31. Accurate information on the cost determinants in the COVID-19 patients could provide policymakers a valuable planning tool for dealing with the future COVID-19 crises especially in the health systems with limi...

    Authors: Vajihe Ramezani-Doroh, Leili Tapak, Yadollah Hamidi, Saeid Bashirian, Ali Reza Soltanian, Mahyar Motaghed, Ebrahim Ghelichkhani and Elaheh Talebi-Ghane
    Citation: Cost Effectiveness and Resource Allocation 2022 20:52
  32. The objective of this paper is to assess the economic profile of Enzyme Replacement Therapy (ERT) to symptomatic patients with Pompe, Fabry, Gaucher disease and Lysosomal acid lipase (LAL) deficiency.

    Authors: Eleni Ioanna Katsigianni and Panagiotis Petrou
    Citation: Cost Effectiveness and Resource Allocation 2022 20:51

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2022 20:64

  33. Given the human and economic cost of the COVID-19 pandemic, protecting healthcare workers (HCW) and ensuring continuity of care is critical. The aim of this study is to evaluate the cost-effectiveness of diffe...

    Authors: Roberto Benoni, Irene Campagna, Francesca Moretti and Stefano Tardivo
    Citation: Cost Effectiveness and Resource Allocation 2022 20:50
  34. Despite the high HIV associated burden, Mozambique lacks data on HIV counselling and testing (HCT) costs. To help guide national HIV/AIDS programs, we estimated the cost per test for voluntary counselling and ...

    Authors: Jun Hao Choo, Elisa Lopez-Varela, Laura Fuente-Soro, Orvalho Augusto, Charfudin Sacoor, Ariel Nhacolo, Stanley Wei, Denise Naniche, Ranjeeta Thomas and Elisa Sicuri
    Citation: Cost Effectiveness and Resource Allocation 2022 20:49
  35. In Germany, CRT devices with defibrillator capability (CRT-D) have become the predominant treatment strategy for patients with heart failure and cardiac dyssynchrony. However, according to current guidelines, ...

    Authors: Moritz Hadwiger, Laura Schumann, Nora Eisemann, Nikolaos Dagres, Gerhard Hindricks, Janina Haug, Michael Wolf, Ursula Marschall, Alexander Katalinic and Fabian-Simon Frielitz
    Citation: Cost Effectiveness and Resource Allocation 2022 20:48
  36. Despite ample international knowledge on cost-effectiveness of total knee arthroplasty (TKA), it has never been a subject of investigation in Kazakhstan or other post-Soviet economies. Our study aimed to carry...

    Authors: Dinara Serikova-Esengeldina, Natalya Glushkova, Gulzada Abdushukurova, Akmaral Mussakhanova, Ainur Mukhamejanova, Zaituna Khismetova, Dmitry Bokov, Alexandr Ivankov, Maiya Goremykina and Yuliya Semenova
    Citation: Cost Effectiveness and Resource Allocation 2022 20:47
  37. Drug reimbursement decisions are often made based on a price set by the manufacturer. In some cases, this price leads to public and scientific debates about whether its level can be justified in relation to it...

    Authors: Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer and Werner B. F. Brouwer
    Citation: Cost Effectiveness and Resource Allocation 2022 20:46
  38. This study aimed to examine the economic and clinical benefits of a new powered circular stapler for left-sided colorectal construction in China.

    Authors: Junwei Bai, Yingnan Zhao, Hong Liang, Junmeng Li and Chao Zhang
    Citation: Cost Effectiveness and Resource Allocation 2022 20:45
  39. During recent years, overuse of medical imaging especially computed tomography has become a serious concern. We evaluated the suitable usage of chest computed tomography (CT)-scan, in patients hospitalized in ...

    Authors: Ramiz Kamrani, Mohammad Javad Fallahi, Seyed Masoom Masoompour, Seiyed Mohammad Ali Ghayumi, Reza Jalli, Sepideh Khederzadeh and Amirhossein Erfani
    Citation: Cost Effectiveness and Resource Allocation 2022 20:44
  40. The objective of this study is the evaluation of routine chest radiography following the placement of Implantable venous access port catheter (IVAPC) central lines using combined ultrasound and fluoroscopic gu...

    Authors: Hamed Ghoddusi Johari, Mohammad Reza Saki, Amirhossein Erfani, Reza Shahriarirad and Keivan Ranjbar
    Citation: Cost Effectiveness and Resource Allocation 2022 20:43
  41. Malaria in pregnancy remains a major health threat in sub-Saharan Africa to both expectant mothers and their unborn children. To date, there have been very few studies focused on the out of pocket costs associ...

    Authors: Laetitia Duval, Elisa Sicuri, Susana Scott, Maminata Traoré, Bunja Daabo, Halidou Tinto, Koen Peeters Grietens, Umberto d’Alessando, Henk Schallig, Petra Mens and Lesong Conteh
    Citation: Cost Effectiveness and Resource Allocation 2022 20:42
  42. Urban family physician program (UFPP) is initiated as pilot by policy makers as a main reform in future of primary health care in Iran. Despite an ongoing pilot implementation of this program from 2012, it rem...

    Authors: Mohsen Bayati, Arash Rashidian, Vahid Yazdi-Feyzabadi and Sajad Delavari
    Citation: Cost Effectiveness and Resource Allocation 2022 20:41
  43. Patient-centered care (PCC) approach has continued to gain recognition globally as the key to providing quality healthcare. However, this concept is not fully integrated into the management of primary health c...

    Authors: Monsurat Adepeju Lateef and Euphemia Mbali Mhlongo
    Citation: Cost Effectiveness and Resource Allocation 2022 20:40
  44. We evaluate the cost-effectiveness of the ‘Best Care’ integrated disease management (IDM) program for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease (COPD) compared to usual...

    Authors: Andrew D. Scarffe, Christopher J. Licskai, Madonna Ferrone, Kevin Brand, Kednapa Thavorn and Doug Coyle
    Citation: Cost Effectiveness and Resource Allocation 2022 20:39
  45. In the outpatient management of severe wasting, routine antibiotic therapy is recommended for all children upon admission regardless of whether clinical signs of infection are present. Indicated antibiotic the...

    Authors: Sheila Isanaka, Kevin Tang, Fatou Berthé, Rebecca F. Grais and Ankur Pandya
    Citation: Cost Effectiveness and Resource Allocation 2022 20:38
  46. Chronic kidney disease (CKD) is a health problem due to its increasing prevalence and imposes a significant economic burden on the health system. This study aimed to analyze the cost–benefit of kidney transpla...

    Authors: Farzaneh Abdi, Cyrus Alinia, Ali Taghizadeh Afshari and Hasan Yusefzadeh
    Citation: Cost Effectiveness and Resource Allocation 2022 20:37
  47. Benchmark data on the population-level economic burden are critical to inform policymakers about liver cancer control. However, comprehensive data in China are currently limited.

    Authors: Meng-Di Cao, Cheng-Cheng Liu, Hong Wang, Lin Lei, Maomao Cao, Yuting Wang, He Li, Xin-Xin Yan, Yan-Jie Li, Xin Wang, Ji Peng, Chunfeng Qu, Eleonora Feletto, Ju-Fang Shi and Wanqing Chen
    Citation: Cost Effectiveness and Resource Allocation 2022 20:36
  48. In recent years, due to the increasing number of cross-regional medical patients, countries around the world have issued a series of policies or regulations to reduce their out-of-pocket burden. In this contex...

    Authors: Bokai Zhang, Haixin Wang, Hongyu Zhang, Guomei Tian, Ting Zhang, Qi Shi, Jian Liu, Jinpeng Xu, Jingchu Liu, Qunhong Wu and Zheng Kang
    Citation: Cost Effectiveness and Resource Allocation 2022 20:35

Annual Journal Metrics